Afatinib Dimaleate 30 mg (Generic)

What is Afatinib Dimaleate 30 mg?

Afatinib Dimaleate 30 mg is a prescription medication primarily used in the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as tyrosine kinase inhibitors and works by blocking signals that promote the growth and spread of cancer cells. Manufactured by Boehringer Ingelheim India Pvt.Ltd, this product offers targeted therapy designed to manage specific genetic mutations associated with NSCLC.

This medicine is formulated to help patients with advanced stages of lung cancer where tumor cells have mutations in the epidermal growth factor receptor (EGFR). By selectively inhibiting the EGFR pathway, Afatinib Dimaleate 30 mg aims to slow down tumor progression and help improve patient outcomes.

Afatinib Dimaleate 30 mg is intended for those diagnosed with NSCLC who may have limited options with conventional chemotherapy. Its oral administration provides a convenient treatment approach under medical guidance. Understanding its role, benefits, and proper use is vital for patients and caregivers considering this therapy in their cancer treatment plan.

Uses of Afatinib Dimaleate 30 mg

• Treatment of non-small cell lung cancer
• Management of NSCLC patients with EGFR mutations
• Targeted therapy for patients with metastatic or locally advanced NSCLC
• Option for first-line treatment in specific genetic profiles

How Afatinib Dimaleate 30 mg Works

Afatinib Dimaleate 30 mg functions as an irreversible blocker of the epidermal growth factor receptor (EGFR) family of tyrosine kinases. By inhibiting these receptors, it disrupts the signaling pathways that cancer cells rely on to multiply and survive. This targeted action helps control tumor growth and may reduce the spread of cancer cells within the body.

Unlike traditional chemotherapy, Afatinib offers a more selective approach, targeting specific mutations linked to lung cancer development. This mechanism makes it a vital option for patients whose tumors express these mutations, offering improved efficacy with a potentially different side effect profile.

How to take Afatinib Dimaleate 30 mg

Afatinib Dimaleate 30 mg is administered orally, usually once daily with or without food. It is important to take the medication at the same time each day to maintain consistent blood levels. Swallow the tablet whole with water and avoid breaking or chewing it.

Patients must follow their healthcare provider’s dosing instructions carefully. Do not adjust the dose or stop taking the medication without consulting a physician. Regular monitoring during treatment ensures the medicine is effective and side effects are managed.

Benefits of Afatinib Dimaleate 30 mg

• Targeted treatment for EGFR mutation-positive NSCLC
• Oral administration for convenient dosing
• Potential to improve progression-free survival
• Reduces tumor growth and spread
• Alternative to traditional chemotherapy with a specific mechanism

Dosage and Administration

The typical dosage of Afatinib Dimaleate 30 mg is one tablet taken orally once daily. Your healthcare provider will tailor the dose based on your medical condition, response to treatment, and tolerance. Dose adjustments may be necessary in the case of side effects or other health concerns.

It is critical not to exceed the recommended dose. Missed doses should be taken as soon as remembered unless it is close to the next dose. Never double the dose to make up for a missed one.

Who Should Use Afatinib Dimaleate 30 mg?

Afatinib Dimaleate 30 mg is indicated for adults diagnosed with non-small cell lung cancer, particularly those whose tumors carry specific EGFR mutations. It is suitable for patients requiring targeted therapy for locally advanced or metastatic NSCLC. Use should be under the supervision of an oncologist familiar with this treatment.

Who Should Avoid Afatinib Dimaleate 30 mg?

Patients with known hypersensitivity to Afatinib Dimaleate or any component of the formula should avoid this medication. It is not recommended for use in individuals without EGFR mutation-positive NSCLC. Caution is advised for patients with severe liver or kidney impairment or those with pre-existing medical conditions requiring consultation.

Side Effects of Afatinib Dimaleate 30 mg

• Diarrhea
• Skin rash
• Mouth sores
• Nausea
• Fatigue
• Decreased appetite
• Stomatitis
• Dry skin
• Itching
• Increased liver enzymes

Safety Advice

• Inform your doctor about all medical conditions and allergies.
• Report severe or persistent side effects immediately.
• Avoid sun exposure due to increased skin sensitivity.
• Do not operate heavy machinery if feeling dizzy or fatigued.
• Maintain regular blood tests as recommended by your healthcare provider.
• Stay hydrated and manage diarrhea promptly.
• Do not discontinue medication without medical advice.

Drug Interactions

• Other cancer therapies, including chemotherapy and radiation
• Strong CYP3A4 inhibitors or inducers
• Medications affecting liver enzymes
• Antacids and proton pump inhibitors may affect absorption

Storage Instructions

Store Afatinib Dimaleate 30 mg tablets at room temperature, away from moisture and heat. Keep the container tightly closed and out of reach of children. Do not use after the expiration date printed on the packaging.

Where to buy Afatinib Dimaleate 30 mg in Malaysia?

Afatinib Dimaleate 30 mg can be purchased at licensed pharmacies and healthcare facilities in Malaysia with a valid prescription. It is important to buy from authorized sources to ensure the quality and authenticity of the product. Consult your oncologist or healthcare provider for reliable purchase options within Malaysia.

Frequently Asked Questions (FAQ)

What is the price of Afatinib Dimaleate 30 mg in Malaysia?

The price of Afatinib Dimaleate 30 mg in Malaysia varies depending on the pharmacy and location. It is advised to check with authorized local pharmacies or healthcare providers for the most accurate pricing information.

What happens if I miss a dose?

If you miss a dose of Afatinib Dimaleate 30 mg, take it as soon as you remember unless it is close to the time for your next dose. Do not double the dose to make up for the missed one; follow your doctor’s instructions.

Where can I find Afatinib Dimaleate 30 mg for sale?

You can find Afatinib Dimaleate 30 mg at licensed medical pharmacies in Malaysia or through healthcare institutions upon presentation of a prescription from a qualified physician.

Is Afatinib Dimaleate 30 mg available in Malaysia?

Yes, Afatinib Dimaleate 30 mg is available in Malaysia through authorized pharmacies and hospitals. It requires a prescription and is dispensed under medical supervision.

Can Afatinib Dimaleate 30 mg be used with other cancer treatments?

Afatinib Dimaleate 30 mg may be used alongside other therapies but only under close medical supervision to avoid adverse interactions. Your oncologist will determine the best treatment plan for you.

What should I do if I experience severe side effects?

If you experience severe or unusual side effects while taking Afatinib Dimaleate 30 mg, contact your healthcare provider immediately for advice and possible adjustments to your treatment.

Is it safe to take Afatinib Dimaleate 30 mg during pregnancy?

Afatinib Dimaleate 30 mg is generally not recommended during pregnancy due to potential risks to the fetus. Always inform your doctor if you are pregnant or planning to become pregnant before starting treatment.

Conclusion

Afatinib Dimaleate 30 mg offers an effective targeted therapy option for patients with EGFR mutation-positive non-small cell lung cancer. Manufactured by Boehringer Ingelheim India Pvt.Ltd, it provides focused action to help manage advanced NSCLC with a convenient oral dosage form. Proper administration, adherence to safety guidelines, and medical supervision are essential to maximize benefits while minimizing side effects. For patients in Malaysia seeking specialized lung cancer treatment, Afatinib Dimaleate 30 mg represents a significant advancement in personalized oncology care.